Ipca Laboratories Ltd. (IPCALAB) Share Price Falls 3.19% to Rs 1,681.40

Ipca Laboratories Ltd. Share Price Today fell to Rs 1,681.40, down 3.19%. The large-cap healthcare stock now has a market capitalisation of Rs 44,064.62 crore.

Ipca Laboratories Ltd. Share Price fell to Rs 1,681.40 on 10 August 2026, down 3.19% for the day, as the stock lost Rs 55.45 from its previous close of Rs 1,736.85. With a market capitalisation of Rs 44,064.62 crore, the move drew attention because it placed the company among the more notable large-cap top decliner names in Stock Market Today trade. The supplied data confirms the price event and the scale of the share price decline, though it does not establish a company-specific catalyst behind the move.

Ipca Laboratories Ltd. Share Price Today also trended because the stock opened at Rs 1,721.20, touched an intraday high of Rs 1,743.00 and then slipped to a low of Rs 1,675.00 before trading near that weaker zone. That intraday swing shows sellers retained control through much of the session rather than the decline being limited to a brief opening reaction. For readers tracking Ipca Laboratories Ltd. Stock News, the day’s price action matters because the fall came in a company that still sits well above the average market capitalisation of its supplied healthcare sector benchmark universe.

From a research perspective, Univest views this as an event-led Ipca Laboratories Ltd. Share Price Update: what happened is clear, the stock is falling today, and the relevant next step is to examine volume participation, sector context, peer positioning and what the company’s scale says about investor attention. In other words, this was not a today’s rally story in Market News; it was a large-cap price fall that deserves measured stock analysis.

Ipca Laboratories Ltd. (IPCALAB) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,681.4
Previous Close	Rs 1,736.85
Today's Change	Rs -55.45 (-3.19%)
Day Open	Rs 1,721.2
Day High	Rs 1,743
Day Low	Rs 1,675
Current Volume (BSE)	17,959
BSE Traded Volume	17,959
NSE Traded Volume	2,16,448
Combined NSE + BSE Volume	2,34,407
Turnover	Rs 3.02 crore
Market Capitalisation	Rs 44,064.62 crore
Market Cap Category	Large Cap

Ipca Laboratories Ltd. (IPCALAB) traded at Rs 1,681.4. versus the previous close of Rs 1,736.85, a fall of 3.19%. The stock opened at Rs 1,721.2, reached Rs 1,743, touched Rs 1,675. Reported volume was 17,959.

Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 44,064.62 crore

Ipca Laboratories Ltd. Share Price is drawing investor attention mainly through market position and scale in the supplied data. With a market capitalisation of Rs 44,064.62 crore, the company stands far above the healthcare benchmark universe averages included in the dataset, making it one of the larger listed names within the comparison set presented here.

For Ipca Laboratories Ltd. Fundamental Analysis, the most concrete company-level figure supplied is market capitalisation at Rs 44,064.62 crore. Market capitalisation measures company size, not business quality by itself, but size does matter when interpreting a sharp single-session move. A 3.19% decline in a company of this scale naturally attracts more attention in the Indian Stock Market than a similar move in a far smaller stock. It also means the stock can show up prominently in Market Movers and Stocks Falling Today screens even without any verified company-specific trigger in the dataset.

The day’s turnover of Rs 3.02 crore adds another layer. While turnover alone is not a valuation metric, it helps frame how much capital changed hands during the decline. The combination of a large market cap, a noticeable single-day fall and active exchange participation explains why Ipca Laboratories Ltd. Stock News has become a live search topic. In financial analysis terms, this is first a price action event and then a context exercise: investors usually look at scale, sector standing and relative valuation conditions before forming a broader view.

The supplied dataset does not provide company-specific P/E Ratio, P/B Ratio, ROE, ROCE, EPS, Book Value, Dividend Yield, debt or cash-flow metrics for this article, so the most reliable way to extend Ipca Laboratories Ltd. Share Price analysis is through the verified sector benchmark and peer universe that follow. That broader comparison can still help frame whether the stock’s current market attention sits in a rich, average or mixed valuation environment within Healthcare. Univest therefore shifts from pure price action to sector and peer positioning rather than turning this move into an unsupported recommendation.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	26.63x
Benchmark Average P/E	92.4x
Benchmark P/E Range	3.21x to 3,417.8x
Benchmark Median P/B	1.9x
Benchmark Median ROE	10.71%
Benchmark Median ROCE	13.16%
Company Market Capitalisation	Rs 44,064.62 crore
Benchmark Median Market Cap	Rs 130.8 crore

Ipca Laboratories Ltd. (IPCALAB) is classified under sector: Healthcare.

Track today’s top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Ipca Laboratories Ltd. Share Price is moving lower inside a Healthcare benchmark universe where valuation and profitability readings are spread across a very wide range. The sector numbers show a large dispersion in P/E and P/B ratios, which means context matters more than one headline multiple.

The supplied sector for the company is Healthcare. Within the same-sector benchmark scope, the dataset covers 202 companies for market capitalisation and P/E analysis, 201 companies for P/B, ROE and ROCE, and provides a direct statistical backdrop for sector analysis. The benchmark median P/E stands at 26.63, while the average P/E is 92.40 across 157 companies, with a minimum of 3.21 and a maximum of 3,417.80. That wide spread suggests the Healthcare basket includes both modestly valued and very highly valued names, so investors need to read any individual stock move against a broad valuation range rather than a narrow benchmark.

On price-to-book, the sector median is 1.90 and the average is 2.74 across 201 companies, with the range running from -22.33 to 59.75. Profitability also varies meaningfully. The sector median ROE is 10.71 and average ROE is 14.58, while median ROCE is 13.16 and average ROCE is 16.61. Those figures show that Healthcare, as represented here, contains a mixture of weaker and stronger capital-return profiles.

Market-cap context is especially useful for Ipca Laboratories Ltd. Share Price. The benchmark median market capitalisation is Rs 130.80 crore and the average is Rs 460.68 crore, with the largest company in this supplied benchmark set at Rs 3,032.97 crore. Against that backdrop, Ipca Laboratories Ltd. Market Cap of Rs 44,064.62 crore is dramatically larger than the benchmark median, average and maximum listed in this sector snapshot. That does not explain the share price fall by itself, but it does explain why the stock’s intraday decline is more visible in Share Market Today coverage and why it can influence sentiment around healthcare market updates more than smaller peers.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	3,032.97	31.12	0.45	-2.89	-0.26
Hikal Ltd.	HIKAL	2,799.54	0	2.35	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,707.2	40.2	8.18	28.21	26.35
Beta Drugs Ltd.	BETA	2,631.45	63.43	6.27	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,537.93	33.3	6.87	-2.6	16.92

Ipca Laboratories Ltd. (IPCALAB) has a market capitalisation of Rs 44,064.62 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Ipca Laboratories Ltd. Share Price can also be framed through the supplied peer set, which includes listed Healthcare names across Pharmaceuticals & Drugs and Hospital & Healthcare Services. The peer data shows that most companies in this comparison basket are materially smaller by market capitalisation than Ipca Laboratories Ltd.

Among the listed peers supplied, Dishman Carbogen Amcis Ltd. has a market capitalisation of Rs 3,032.97 crore with a P/E of 31.12, P/B of 0.45, ROE of -2.89% and ROCE of -0.26%. Hikal Ltd. stands at Rs 2,799.54 crore with P/B of 2.35, ROE of 15.22% and ROCE of 16.15%. Kwality Pharmaceuticals Ltd. is valued at Rs 2,707.20 crore with P/E of 40.20, P/B of 8.18, ROE of 28.21% and ROCE of 26.35%. Beta Drugs Ltd. has a market capitalisation of Rs 2,631.45 crore with P/E of 63.43, P/B of 6.27, ROE of 18.65% and ROCE of 22.17%.

The set also includes Dr Agarwals Eye Hospital Ltd. at Rs 2,537.93 crore with P/E of 33.30, P/B of 6.87, ROE of -2.60% and ROCE of 16.92%; Panacea Biotec Ltd. at Rs 2,531.49 crore with P/B of 3.03, ROE of 0.00% and ROCE of 5.36%; Sai Parenteral’s Ltd. at Rs 2,513.58 crore with P/E of 176.28, P/B of 3.26, ROE of 13.90% and ROCE of 12.97%; Solara Active Pharma Sciences Ltd. at Rs 2,422.79 crore with P/B of 1.90, ROE of 17.23% and ROCE of 15.34%; NGL Fine-Chem Ltd. at Rs 2,118.60 crore with P/E of 44.02, P/B of 6.43, ROE of 27.90% and ROCE of 33.91%; and Venus Remedies Ltd. at Rs 2,068.61 crore with P/E of 17.81, P/B of 3.01, ROE of 9.85% and ROCE of 7.89%.

The key conclusion from this peer comparison is scale. Ipca Laboratories Ltd. Share Price belongs to a company whose Rs 44,064.62 crore market cap is many times larger than every supplied peer, even the largest one at Rs 3,032.97 crore. Because no company-specific valuation or profitability ratios are supplied for Ipca Laboratories Ltd., the most defensible peer insight is not whether it is richer or cheaper, but that the market is reacting to a much larger healthcare name than the rest of the displayed comparison basket. That difference in size alone can change how investors interpret daily price action and sector significance.

Why Investors Are Watching Ipca Laboratories Ltd.

Ipca Laboratories Ltd. Share Price is being watched because a 3.19% single-day fall in a large-cap healthcare stock is not a routine background move. The decline to Rs 1,681.40, combined with a low-close pattern and total volume of 2,34,407 shares, has pushed the stock into active market discussion across NSE News, BSE News and broader stock updates.

• Verified price action: the stock fell Rs 55.45 from Rs 1,736.85 to Rs 1,681.40 and traded between Rs 1,743.00 and Rs 1,675.00.
• Large-cap context: the company is tagged Large Cap with a market capitalisation of Rs 44,064.62 crore.
• Trading participation: total volume reached 2,34,407 shares, including 2,16,448 on NSE and 17,959 on BSE, with turnover of Rs 3.02 crore.
• Sector backdrop: the Healthcare benchmark shows wide valuation dispersion, with median P/E at 26.63 and average P/E at 92.40.
• Peer positioning: the supplied peer set is much smaller in market cap, making this move notable from a sector-weight perspective.

What should investors monitor next? The most relevant indicators from the supplied data are whether Ipca Laboratories Ltd. Share Price continues to trade near the day’s weak zone, how future volume compares with this session’s 2,34,407 shares, and whether the stock remains a top decliner relative to other Healthcare names. Univest would also track whether fresh sector or company disclosures change the context around this price action.

About Ipca Laboratories Ltd.

Ipca Laboratories Ltd. Share Price is being analysed here within the Healthcare sector, which is the verified company classification supplied in the dataset. Beyond that, the provided comparison universe places the stock alongside businesses from Pharmaceuticals & Drugs and Hospital & Healthcare Services, giving investors a practical market context for where the company is being screened in sector-based analysis.

From a market-structure perspective, this means Ipca Laboratories Ltd. is being judged not only on its own price action but also in relation to how healthcare companies are valued and traded across the listed space. The same-sector benchmark spans 202 companies, while the peer basket includes names such as Dishman Carbogen Amcis, Hikal, Kwality Pharmaceuticals, Beta Drugs, Dr Agarwals Eye Hospital, Panacea Biotec, Sai Parenteral’s, Solara Active Pharma Sciences, NGL Fine-Chem and Venus Remedies. That breadth matters because it shows the company sits inside a diverse Healthcare market landscape rather than a narrow one-stock story.

For readers following Ipca Laboratories Ltd. Share News or Ipca Laboratories Ltd. Latest News, the main takeaway is that this stock is part of a sector where company sizes, valuation multiples and profitability levels vary sharply. As a result, even one day of market decline can trigger broad interest when it occurs in a company whose market capitalisation is vastly larger than the average and median names represented in the supplied healthcare benchmark. Univest therefore treats the stock as a significant sector event rather than only a routine tape move.

Track Ipca Laboratories Ltd. Share Price on Univest

Use Ipca Laboratories Ltd. (IPCALAB) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Investors tracking Ipca Laboratories Ltd. Share Price can use Univest to follow live share price moves, daily stock performance, 52 week levels, market capitalisation, price action trends and broader market insights. Univest also helps users monitor ratio-based stock analysis, sector comparisons, peer positioning and shareholding pattern updates when available. For those searching Ipca Laboratories Ltd. Share Price Live, Ipca Laboratories Ltd. Stock News or Ipca Laboratories Ltd. Share Price Update, the value lies in viewing intraday movement alongside fundamentals, sector benchmarks and event-based screens rather than in isolation. That makes it easier to place a single-session price fall in a broader research framework without turning a news event into a recommendation.

Frequently Asked Questions

Why is Ipca Laboratories Ltd. Share Price falling today?

Ans. Ipca Laboratories Ltd. Share Price fell 3.19% to Rs 1,681.40 on 10 August 2026, down Rs 55.45 from Rs 1,736.85. The supplied data confirms the price fall and intraday weakness, but it does not identify a company-specific catalyst.

What is Ipca Laboratories Ltd. Share Price Today?

Ans. Ipca Laboratories Ltd. Share Price Today is Rs 1,681.40. The stock traded between Rs 1,743.00 and Rs 1,675.00 during the session after opening at Rs 1,721.20, showing a broad intraday range and a close near weaker levels.

How much did Ipca Laboratories Ltd. stock fall today?

Ans. Ipca Laboratories Ltd. stock fell Rs 55.45, which translates into a 3.19% decline for the day. The move took the stock from the previous close of Rs 1,736.85 to a current price of Rs 1,681.40.

Is Ipca Laboratories Ltd. a large-cap stock?

Ans. Yes, the supplied dataset classifies Ipca Laboratories Ltd. as a Large Cap stock. Its market capitalisation is Rs 44,064.62 crore, which makes the day’s 3.19% decline more visible in broad market screens and stock updates.

What does today’s trading range show for Ipca Laboratories Ltd. Share Price?

Ans. The trading range of Rs 1,743.00 to Rs 1,675.00 shows that Ipca Laboratories Ltd. Share Price saw notable intraday volatility. Because the stock was trading near the lower end of that range, the session reflected sustained selling pressure rather than.

How much volume was traded in Ipca Laboratories Ltd. shares today?

Ans. Total traded volume in Ipca Laboratories Ltd. shares stood at 2,34,407. Of this, NSE volume was 2,16,448 and BSE volume was 17,959, while the supplied turnover for the session was Rs 3.02 crore.

How does Ipca Laboratories Ltd. Market Cap compare with the healthcare benchmark?

Ans. Ipca Laboratories Ltd. Market Cap is Rs 44,064.62 crore, far above the supplied healthcare benchmark median of Rs 130.80 crore and average of Rs 460.68 crore. It is also above the benchmark maximum listed in the sector snapshot.

What does the healthcare sector benchmark indicate?

Ans. The Healthcare benchmark covers 202 companies and shows wide valuation dispersion. Median P/E is 26.63 and average P/E is 92.40, while median ROE is 10.71 and median ROCE is 13.16, indicating mixed sector financial profiles.

How does Ipca Laboratories Ltd. compare with the supplied peers?

Ans. Ipca Laboratories Ltd. stands out mainly on scale. Its market capitalisation of Rs 44,064.62 crore is far above every supplied peer, whose market caps range from Rs 2,068.61 crore to Rs 3,032.97 crore in this comparison set.

What should investors track next in Ipca Laboratories Ltd. Stock News?

Ans. Investors can track whether Ipca Laboratories Ltd. Share Price continues to hold near Rs 1,681.40, whether volume stays elevated relative to today’s 2,34,407 shares, and whether the stock remains among top decliner names in Healthcare screens.